Inicio/Acciones/NRSN

NRSN

USD

NeuroSense Therapeutics Ltd. Ordinary Shares

$1.040-0.010 (-0.952%)

Precio en Tiempo Real

Healthcare

Biotecnología

Israel

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.050

Máximo

$1.100

Mínimo

$1.020

Volumen

0.03M

Fundamentos de la Empresa

Capitalización de Mercado

30.7M

Industria

Biotecnología

País

Israel

Estadísticas de Negociación

Volumen Promedio

0.60M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.8Actual $1.040Máximo $2.6

Informe de Análisis de IA

Última actualización: 31 oct 2025

Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

NRSN: A Biotech Bargain With Technical Headwinds

Overview

NeuroSense Therapeutics Ltd (NRSN) trades at $1.03 as of October 30, 2025, nearing its 52-week low of $0.80. The clinical-stage biotech focuses on ALS, Alzheimer's, and Parkinson's treatments, with PrimeC in late-stage trials. Despite a bearish technical setup, its P/E ratio (-1.88x) undercuts the industry average (-2.8x), suggesting potential undervaluation.

Key Technical Signals

Weak Bearish Momentum

DMI Indicator: A bearish trend is detected (ADX:13.2, +DI:8.8, -DI:16.7), though weak trend strength reduces reliability.
MACD Death Cross: Bearish momentum with MACD (-0.0026) below signal line (-0.0022), but the narrow gap implies limited urgency.